Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Merck |
---|---|
Information provided by: | Merck |
ClinicalTrials.gov Identifier: | NCT00565006 |
This study will investigate the influence of MK0859 on ambulatory blood pressure, and how safe and tolerable MK0859 is on the subjects This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
Condition | Intervention | Phase |
---|---|---|
Ambulatory Blood Pressure |
Drug: MK0859 |
Phase I |
Study Type: | Observational |
Ages Eligible for Study: | 45 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 2007_656 |
Study First Received: | November 27, 2007 |
Last Updated: | November 27, 2007 |
ClinicalTrials.gov Identifier: | NCT00565006 |
Health Authority: | United States: Food and Drug Administration |